DK2895856T3 - Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi - Google Patents
Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgiInfo
- Publication number
- DK2895856T3 DK2895856T3 DK13837424.4T DK13837424T DK2895856T3 DK 2895856 T3 DK2895856 T3 DK 2895856T3 DK 13837424 T DK13837424 T DK 13837424T DK 2895856 T3 DK2895856 T3 DK 2895856T3
- Authority
- DK
- Denmark
- Prior art keywords
- fibromyalgy
- diagnosis
- blade
- treatment
- gas
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701923P | 2012-09-17 | 2012-09-17 | |
| US201361762632P | 2013-02-08 | 2013-02-08 | |
| PCT/US2013/055626 WO2014042828A2 (en) | 2012-09-17 | 2013-08-19 | Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2895856T3 true DK2895856T3 (da) | 2017-11-20 |
Family
ID=50278832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13837424.4T DK2895856T3 (da) | 2012-09-17 | 2013-08-19 | Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9702884B2 (da) |
| EP (1) | EP2895856B1 (da) |
| KR (1) | KR102203568B1 (da) |
| AU (1) | AU2013315981B2 (da) |
| CA (1) | CA2884413C (da) |
| DK (1) | DK2895856T3 (da) |
| ES (1) | ES2646598T3 (da) |
| HK (1) | HK1207420A1 (da) |
| MX (2) | MX2015003326A (da) |
| WO (1) | WO2014042828A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
| ES2646598T3 (es) | 2012-09-17 | 2017-12-14 | Cedars-Sinai Medical Center | Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia |
| PL3054977T3 (pl) * | 2013-10-09 | 2021-12-20 | Cedars-Sinai Medical Center | Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelit |
| CA2962493C (en) * | 2014-10-09 | 2023-01-10 | Cedars-Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
| WO2017055467A1 (en) * | 2015-09-29 | 2017-04-06 | Paris Sciences Et Lettres - Quartier Latin | Polypeptides comprising vinculin binding sites for the treatment of proliferation and/or adhesion related diseases |
| AU2018212924A1 (en) * | 2017-01-30 | 2019-07-04 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
| CN114895025A (zh) * | 2021-07-01 | 2022-08-12 | 浙江大学 | 一种检测抗粘着斑蛋白-IgG抗体的试剂盒 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69133348T3 (de) | 1990-10-22 | 2011-05-12 | Centre for Digestive Diseases Pty, Ltd. | Behandlung von nicht-entzündlichen darmerkrankungen |
| US5691151A (en) | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US6562629B1 (en) * | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| FR2806805A1 (fr) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
| US20030157159A1 (en) | 2002-01-15 | 2003-08-21 | Franklin Lanny Udell | Prevention and treatment of digestive tract infections |
| WO2003097854A2 (en) | 2002-05-17 | 2003-11-27 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| WO2004019907A1 (en) | 2002-08-29 | 2004-03-11 | Activbiotics, Inc. | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| US20070010434A1 (en) | 2002-09-16 | 2007-01-11 | Genetech, Inc. | Novel compositions and methods for the treatment of immune related diseases |
| US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
| EP1664796B1 (en) | 2003-09-15 | 2010-12-15 | Oklahoma Medical Research Foundation | Method of using cytokine assays to diagnose, treat, and evaluate ankylosing spondylitis |
| CA2903388C (en) | 2003-12-05 | 2018-01-16 | Fuso Pharmaceutical Industries, Ltd. | Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| US20090233888A1 (en) | 2005-03-23 | 2009-09-17 | Usc Stevens, University Of Southern California | Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| JP5844961B2 (ja) | 2006-08-02 | 2016-01-20 | サリックス ファーマシューティカルズ， インコーポレイテッド | 放射線直腸ｓ状結腸炎を処置するための組成物および方法 |
| US8148067B2 (en) | 2006-11-09 | 2012-04-03 | Xdx, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| JP5755878B2 (ja) | 2007-07-06 | 2015-07-29 | ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ | リファキシミンの薬剤組成物 |
| EP2223121B1 (en) * | 2007-12-20 | 2012-07-25 | Index Diagnostics AB (publ) | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd |
| KR20100122937A (ko) | 2008-02-26 | 2010-11-23 | 샐릭스 파마슈티컬스 리미티드 | 장 질환의 치료 방법 |
| GB2460717A (en) * | 2008-06-11 | 2009-12-16 | Sense Proteomic Ltd | Autoantibodies for the detection of a predisposition to Lupus |
| KR101493125B1 (ko) | 2008-11-24 | 2015-02-12 | 세다르스-신나이 메디칼 센터 | 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체 |
| US20110294726A1 (en) | 2009-02-11 | 2011-12-01 | Cedars-Sinai Medical Center | Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome |
| EP2396652B1 (en) | 2009-02-11 | 2017-12-13 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel syndrome based on cytolethal distending toxin |
| FR2942541A1 (fr) * | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une vascularite |
| RU2397178C1 (ru) | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса |
| IT1400989B1 (it) * | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
| GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| ES2646598T3 (es) | 2012-09-17 | 2017-12-14 | Cedars-Sinai Medical Center | Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia |
| PL3054977T3 (pl) | 2013-10-09 | 2021-12-20 | Cedars-Sinai Medical Center | Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelit |
| CA2962493C (en) | 2014-10-09 | 2023-01-10 | Cedars-Sinai Medical Center | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
| AU2018212924A1 (en) | 2017-01-30 | 2019-07-04 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
-
2013
- 2013-08-19 ES ES13837424.4T patent/ES2646598T3/es active Active
- 2013-08-19 WO PCT/US2013/055626 patent/WO2014042828A2/en active Application Filing
- 2013-08-19 US US14/428,195 patent/US9702884B2/en active Active
- 2013-08-19 CA CA2884413A patent/CA2884413C/en active Active
- 2013-08-19 AU AU2013315981A patent/AU2013315981B2/en active Active
- 2013-08-19 DK DK13837424.4T patent/DK2895856T3/da active
- 2013-08-19 KR KR1020157009889A patent/KR102203568B1/ko active IP Right Grant
- 2013-08-19 MX MX2015003326A patent/MX2015003326A/es unknown
- 2013-08-19 EP EP13837424.4A patent/EP2895856B1/en active Active
-
2015
- 2015-03-13 MX MX2021003764A patent/MX2021003764A/es unknown
- 2015-08-18 HK HK15108002.2A patent/HK1207420A1/xx unknown
-
2017
- 2017-05-31 US US15/609,959 patent/US9952223B2/en active Active
-
2018
- 2018-03-15 US US15/922,604 patent/US10466254B2/en active Active
-
2019
- 2019-10-07 US US16/594,935 patent/US20200271665A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013315981B2 (en) | 2019-04-18 |
| EP2895856A4 (en) | 2016-06-08 |
| CA2884413A1 (en) | 2014-03-20 |
| EP2895856B1 (en) | 2017-10-04 |
| ES2646598T3 (es) | 2017-12-14 |
| KR102203568B1 (ko) | 2021-01-15 |
| AU2013315981A1 (en) | 2015-03-26 |
| MX2015003326A (es) | 2015-08-12 |
| US10466254B2 (en) | 2019-11-05 |
| WO2014042828A2 (en) | 2014-03-20 |
| EP2895856A2 (en) | 2015-07-22 |
| WO2014042828A3 (en) | 2014-10-16 |
| KR20150058404A (ko) | 2015-05-28 |
| MX2021003764A (es) | 2021-05-27 |
| US20200271665A1 (en) | 2020-08-27 |
| US20150233944A1 (en) | 2015-08-20 |
| US20180364255A1 (en) | 2018-12-20 |
| US9952223B2 (en) | 2018-04-24 |
| US20180088130A1 (en) | 2018-03-29 |
| CA2884413C (en) | 2022-11-01 |
| HK1207420A1 (en) | 2016-01-29 |
| US9702884B2 (en) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC3057969I2 (lt) | Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit | |
| DK2895856T3 (da) | Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi | |
| BR112015003320A2 (pt) | aparelhos e métodos eletrocirúrgicos. | |
| DK3421486T5 (da) | Nye Vista-IG-konstruktioner og anvendelse af Vista-IG til behandling af autoimmune, allergiske og inflammatoriske lidelser | |
| DK2935303T3 (da) | 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV | |
| BR112014010175A2 (pt) | unidades de filtro, componentes e recursos destas e métodos de uso e construção | |
| DK2815769T3 (da) | Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet | |
| DK2753632T3 (da) | Neuroaktive steroider, sammensætninger og anvendelse heraf | |
| DK2927311T3 (da) | Celleovervågningsindretning, celleovervågningsfremgangsmåde og program dertil | |
| BR112013009708A2 (pt) | aparelhos, métodos e composições para tratamento endodôntico | |
| DK3027208T3 (da) | Cancerdiagnose og -terapi, der involverer cancerstamceller | |
| BR112013013584A2 (pt) | endoscópio, e, método | |
| DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
| BR112012031232A2 (pt) | método, dispositivo e uso | |
| BR112014033075A2 (pt) | dispositivo de gaxeta, e, turbomáquina. | |
| DK3388687T3 (da) | Spændingsapplikationsindretning, rotationsapparat og spændingsapplikationsfremgangsmåde | |
| DK2900279T3 (da) | Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer | |
| DK2827813T3 (da) | Kuldebehandlingsindretning | |
| DK2805670T3 (da) | Forbedringer af og i sammenhæng med oftalmoskoper | |
| DK2877736T3 (da) | Skrue, skruedel og fremgangsmåde dertil | |
| DK2688588T3 (da) | Hurtig- og langtidsvirkende immunologisk terapeutisk middel | |
| BR112014007442A2 (pt) | instrumento oftalmológico, e, método | |
| DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf | |
| DK2816947T3 (da) | Endoskopisk anordning, særlig til medicinsk brug | |
| BR112014029259A2 (pt) | método, aparelho e produto eletrolítico |